1. FRI0059 The efficacy and safety of pegylated recombinant methionyl human soluble tumour necrosis factor receptor type i (peg stnf-ri; p55) in a randomised, placebo-controlled, clinical study of patients with rheumatoid arthritis (ra). (1st June 2001) Authors: Schiff, M; Furst, D; Fleischmann, R; Macri, M; Joh, T; Edwards, CK; Davis, MW Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0084 Peg stnf-ri improves health-related quality of life in patients with rheumatoid arthritis. (1st June 2001) Authors: Tesser, JR; Schiff, MH; Davis, MW; Woolley, JM Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A480 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗